Hong Ji

Senior Director Translational Research at Ridgeline Therapeutics - Basel, N/A, ch

Hong Ji's Contact Details
HQ
N/A
Location
Zürich,Zurich,Switzerland
Company
Ridgeline Therapeutics
Hong Ji's Company Details
Ridgeline Therapeutics logo, Ridgeline Therapeutics contact details

Ridgeline Therapeutics

Basel, N/A, ch • 20 - 49 Employees
BioTech/Drugs

Ridgeline Discovery, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry and leading academics across Europe. In recent years, Ridgeline has assembled an international team of >70 highly experienced drug discovery professionals and built and operated several new successful companies, including Black Diamond Therapeutics (NASDAQ: BDTX), Bright Peak Therapeutics and Monte Rosa Therapeutics (NASDAQ: GLUE). Ridgeline is currently expanding its capabilities in Basel to support further company creation efforts in small molecules, biologics, and gene/cell therapy with focus on oncology and immunology.

Biotechnology
Details about Ridgeline Therapeutics
Frequently Asked Questions about Hong Ji
Hong Ji currently works for Ridgeline Discovery.
Hong Ji's role at Ridgeline Discovery is Senior Director Translational Research.
Hong Ji's email address is ***@ridgelinediscovery.com. To view Hong Ji's full email address, please signup to ConnectPlex.
Hong Ji works in the Research industry.
Hong Ji's colleagues at Ridgeline Therapeutics are Carolin Wanzenried, Isabel Goeller, Frederic Delobel, Amelie Wiederkehr, Oliver Horlacher, Thomas Ryckmans, Eve Jakob and others.
Hong Ji's phone number is N/A
See more information about Hong Ji